The Latest in B-Cell Lymphoma ICYMI

CML: Preventing chemo-induced vascular toxicity

February 21, 2023

Surviving CLL: Higher risk of other cancer DXs

February 17, 2023

CLL

Despite limits, COVID vaccines protect CLL patients

February 6, 2023

CLL

FDA approves pirtobrutinib for r/r mantle cell lymphoma

January 30, 2023

Mantle Cell Lymphoma

Adding venetoclax improves ibrutinib outcomes in CLL

January 23, 2023

CLL

FDA approves first-in-class drug for follicular lymphoma

December 23, 2022

B Cell Lymphoma

MCL: Event-free survival at 2 years bodes well

December 23, 2022

Mantle Cell Lymphoma

CLL phase 3 study: Zanubrutinib bests ibrutinib

December 16, 2022

CLL

Intermittent fasting can lead to type 2 diabetes remission

December 15, 2022

Updated materials and mentoring can boost diversity in dermatology

December 15, 2022

Experts dispel incorrect dogmas in aesthetic medicine

December 15, 2022

ITP: Biologic beat placebo, but few patients improved

December 14, 2022

Migraine: A significant risk factor for cardiovascular diseases

December 14, 2022

How COVID-19 pandemic affected headache-related disability in young adults with migraine

December 14, 2022

Erenumab serves as an effective and safe preventive treatment for migraine

December 14, 2022